BioSpace News Archive

Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, SpinTech, has received FDA 510(k) clearance for their STAGETM magnetic resonance imaging software.

On track to complete planned business separation in 4Q 2021; each company launching with approximately 24 months of runway following separation –

cPass has been awarded the Federal Drug Administration (FDA) Emergency Use Authorization.

VitalHub Corp. is pleased to announce it has been selected to present at Canaccord Genuity’s 41st Annual Growth Conference on August 12, 2021.

Delcath Systems, Inc., an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced that it has entered into a debt facility with Avenue Venture Opportunities Fund, L.P. providing up to $20 million with an initial $15 million funded at close.

Intra-Cellular Therapies, Inc. today announced its financial results for the second quarter ended June 30, 2021 and provided a corporate update

Liminal BioSciences Inc., announced today that, its subsidiary Prometic Biotherapeutics Inc. has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (“PRV”) for USD105M.

Cytocom Inc. today provided an update regarding its portfolio of clinical programs.

Dante Labs announced today the appointment of Mark Morgan as a board member.

Memory Treatment Centers, a PURE Healthcare company (PURE), is excited to announce the completion of their first Aduhelm infusion. Memory Treatment Centers are among the first organizations to administer the new FDA approved Alzheimer’s drug, Aduhelm.